Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201212024 Principal Investigator: Baggstrom, Maria
Title: A phase II, multicenter, single-arm study of oral LDK378 in crizotinib naïve adult patients with ALK-activated non-small cell lung cancer
Phase: II Disease Site: Lung
Participating Site(s):
 
Main Campus
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to determine whether or not a research drug called LDK378 will help control lung cancer in patients whose lung tumors have a genetic change called an ALK mutation.
 
More Information:
ClinicalTrial.gov link
Internal Protocol Documents (requires Siteman administrative database password)